Thioredoxin (TRX) is a potent protein disulfide oxidoreductase important in antioxidant defense and regulation of cell growth and signal transduction processes, among them the production of nitric oxide. We report that lung TRX and its reductase, TR, are specifically upregulated at birth by O₂. Throughout the third trimester, mRNAs for TRX and TR were expressed constitutively at low levels in fetal baboon lungs. However, after premature birth (125 or 140 of 185 days gestation), lung TRX and TR mRNAs increased rapidly with the onset of O₂ or air breathing. Lung TRX mRNA also increased in lungs of term newborns with air breathing. Premature animals (140 days) breathing 100% O₂ develop chronic lung disease within 7-14 days. These animals had greater TRX and TR mRNAs after 1, 6, or 10 days of life than fetal control animals. In 140-day animals given lesser O₂ concentrations (as needed) who do not develop chronic lung disease, lung TRX and TR mRNAs were also increased on days 1 and 6 but not significantly on day 10. In fetal distal lung explant culture, mRNAs for TRX and TR were elevated within 4 h in 95% O₂ relative to 1% O₂, and the response was similar at various gestations. In contrast, TRX protein did not increase in lung explants from premature animals (125 or 140 days) but did in those from near-term (175-day) fetal baboons after exposure to hyperoxia. However, lung TRX protein and activity, as well as TR activity, eventually did increase in vivo in response to hyperoxia (6 days). Increases in TRX and TR mRNAs in response to 95% O₂ also were observed in adult baboon lung explants. When TRX redox status was determined, increased O₂ tension shifted TRX to its oxidized form. Treatment of lung explants with actinomycin D inhibited TRX and TR mRNA increases in 95% O₂, indicating transcriptional regulation by O₂. The acute increase in gene expression for both TRX and TR in response to O₂ suggests an important role for these proteins during the transition from relatively anaerobic fetal life to O₂ breathing at birth.

bronchopulmonary dysplasia; respiratory distress; explant culture

This article has been cited by other articles:

				R. Kaarteenaho-Wiik and V. L. Kinnula Distribution of Antioxidant Enzymes in Developing Human Lung, Respiratory Distress Syndrome, and Bronchopulmonary Dysplasia J. Histochem. Cytochem., September 1, 2004; 52(9): 1231 - 1240. [Abstract] [Full Text] [PDF]

				K. C. Das, P. M. B. Pahl, X.-L. Guo, and C. W. White Induction of Peroxiredoxin Gene Expression by Oxygen in Lungs of Newborn Primates Am. J. Respir. Cell Mol. Biol., August 1, 2001; 25(2): 226 - 232. [Abstract] [Full Text] [PDF]

				H.-S. Kim, S. W. Kang, S. G. Rhee, and L. B. Clerch Rat lung peroxiredoxins I and II are differentially regulated during development and by hyperoxia Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1212 - L1217. [Abstract] [Full Text] [PDF]

				L. A. Miller, J. Usachenko, R. J. McDonald, and D. M. Hyde Trafficking of neutrophils across airway epithelium is dependent upon both thioredoxin- and pertussis toxin-sensitive signaling mechanisms J. Leukoc. Biol., August 1, 2000; 68(2): 201 - 208. [Abstract] [Full Text]

				J. Moskovitz, S. Bar-Noy, W. M. Williams, J. Requena, B. S. Berlett, and E. R. Stadtman Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals PNAS, November 6, 2001; 98(23): 12920 - 12925. [Abstract] [Full Text] [PDF]